121 related articles for article (PubMed ID: 2127402)
1. Systemic therapy of advanced metastatic malignant melanoma with a combination of fibroblast interferon-beta and recombinant interferon-gamma.
Kowalzick L; Weyer U; Lange P; Breitbart EW
Dermatologica; 1990; 181(4):298-303. PubMed ID: 2127402
[TBL] [Abstract][Full Text] [Related]
2. A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma.
Creagan ET; Loprinzi CL; Ahmann DL; Schaid DJ
Cancer; 1988 Dec; 62(12):2472-4. PubMed ID: 3142675
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.
Schiller JH; Storer B; Bittner G; Willson JK; Borden EC
J Interferon Res; 1988 Oct; 8(5):581-9. PubMed ID: 3148669
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma.
Sertoli MR; Bernengo MG; Ardizzoni A; Brunetti I; Falcone A; Vidili MG; Cusimano MP; Appino A; Doveil G; Fortini C
Oncology; 1989; 46(2):96-8. PubMed ID: 2710482
[TBL] [Abstract][Full Text] [Related]
5. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
6. In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.
Liénard D; Lejeune FJ; Ewalenko P
World J Surg; 1992; 16(2):234-40. PubMed ID: 1561804
[TBL] [Abstract][Full Text] [Related]
7. [Alpha 2 -interferon therapy in metastasizing malignant melanoma].
Landthaler M; Geyer C; Papendick U; Braun-Falco O
Dtsch Med Wochenschr; 1987 Jun; 112(23):919-21. PubMed ID: 3582200
[TBL] [Abstract][Full Text] [Related]
8. Finally, a successful adjuvant therapy for high-risk melanoma.
Balch CM; Buzaid AC
J Clin Oncol; 1996 Jan; 14(1):1-3. PubMed ID: 8558183
[No Abstract] [Full Text] [Related]
9. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.
Keilholz U; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; Thomas J; Proebstle TM; Schmittel A; Schadendorf D; Velu T; Negrier S; Kleeberg U; Lehman F; Suciu S; Eggermont AM
J Clin Oncol; 2005 Sep; 23(27):6747-55. PubMed ID: 16170182
[TBL] [Abstract][Full Text] [Related]
10. Increased intracellular killing of bacteria in vitro by monocytes of patients with metastatic melanoma before and during treatment with interferon-gamma and interferon-alpha.
Osanto S; van den Barselaar MT; van Dissel JT
Eur J Cancer; 1991; 27(4):478-82. PubMed ID: 1827724
[TBL] [Abstract][Full Text] [Related]
11. Natural human interferon-beta in metastatic malignant melanoma. A phase II study.
Abdi EA; Tan YH; McPherson TA
Acta Oncol; 1988; 27(6b):815-7. PubMed ID: 3233168
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
Goldberg RM; Ayoob M; Silgals R; Ahlgren JD; Neefe JR
Cancer Treat Rep; 1985; 69(7-8):813-6. PubMed ID: 4016791
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic response of interferon-beta in malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of human lymphoblastoid interferon in advanced malignant melanoma.
Retsas S; Priestman TJ; Newton KA; Westbury G
Cancer; 1983 Jan; 51(2):273-6. PubMed ID: 6821816
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders.
Creagan ET; Schaid DJ; Ahmann DL; Frytak S
Am J Clin Oncol; 1988 Dec; 11(6):652-9. PubMed ID: 3142248
[TBL] [Abstract][Full Text] [Related]
16. Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.
Vaishampayan U; Abrams J; Darrah D; Jones V; Mitchell MS
Clin Cancer Res; 2002 Dec; 8(12):3696-701. PubMed ID: 12473578
[TBL] [Abstract][Full Text] [Related]
17. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
Otto U; Schneider A; Denkhaus H; Conrad S
Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
[TBL] [Abstract][Full Text] [Related]
19. Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine.
Flodgren P; Borgström S; Jönsson PE; Lindström C; Sjögren HO
Int J Cancer; 1983 Dec; 32(6):657-65. PubMed ID: 6654521
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma.
Foon K; Doroshow J; Bonnem E; Fefer A; Graham S; Grosh B; Narayan P; Elias L; Harvey H; Schulof R
J Biol Response Mod; 1988 Dec; 7(6):540-5. PubMed ID: 3145964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
